FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2991288125> ?p ?o ?g. }

• W2991288125 endingPage "46557" @default.
• W2991288125 startingPage "46548" @default.
• W2991288125 abstract "Actively targeted nanomedicines have promised to revolutionize cancer treatment; however, their clinical translation has been limited by either low targetability, use of unsafe materials, or tedious fabrication. Here, we developed CD44 and folate receptor (FR) dually targeted nanoparticulate doxorubicin (HA/FA-NP-DOX) based on a direct conjugate of two purely natural ligands, hyaluronic acid and folic acid (FA), for safe, highly specific, and potent treatment of ovarian tumors in vivo. HA/FA-NP-DOX had a small size and high DOX loading, wherein the particle size decreased from 115, 93, to 89 nm with increasing degree of substitution of FA from 6.4, 8.5, to 11.1, while increased from 80, 93, to 103 nm with increasing DOX loading from 15.0, 23.1, to 31.4 wt %. Interestingly, HA/FA-NP-DOX exhibited excellent lyophilization redispersibility and long-term storage stability with negligible drug leakage while it released 91% of DOX in 48 h at pH 5.0. Cellular studies corroborated that HA/FA-NP-DOX possessed high selectivity to both CD44 and FR, resulting in strong killing of CD44- and FR-positive SKOV-3 ovarian cancer cells while low toxicity against CD44- and FR-negative L929 fibroblast cells. In vivo studies revealed a long elimination half-life of 5.6 h, an elevated tumor accumulation of 12.0% ID/g, and an effective inhibition of the SKOV-3 ovarian tumor for HA/FA-NP-DOX, leading to significant survival benefits over free DOX·HCl and phosphate-buffered saline controls. These dually targeted nanomedicines are simple and safe, providing a potentially translatable treatment for CD44- and FR-positive malignancies." @default.
• W2991288125 created "2019-12-05" @default.
• W2991288125 creator A5001549076 @default.
• W2991288125 creator A5015764177 @default.
• W2991288125 creator A5039037778 @default.
• W2991288125 creator A5071660837 @default.
• W2991288125 creator A5072931528 @default.
• W2991288125 creator A5083339231 @default.
• W2991288125 date "2019-11-25" @default.
• W2991288125 modified "2023-10-17" @default.
• W2991288125 title "Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumors" @default.
• W2991288125 cites W1043643217 @default.
• W2991288125 cites W1947798698 @default.
• W2991288125 cites W1955371246 @default.
• W2991288125 cites W1973108158 @default.
• W2991288125 cites W1983655297 @default.
• W2991288125 cites W1997581567 @default.
• W2991288125 cites W2001921621 @default.
• W2991288125 cites W2005159406 @default.
• W2991288125 cites W2008807793 @default.
• W2991288125 cites W2019207861 @default.
• W2991288125 cites W2033281188 @default.
• W2991288125 cites W2041271505 @default.
• W2991288125 cites W2041914114 @default.
• W2991288125 cites W2053422722 @default.
• W2991288125 cites W2054757669 @default.
• W2991288125 cites W2056644518 @default.
• W2991288125 cites W2077236322 @default.
• W2991288125 cites W2078336648 @default.
• W2991288125 cites W2082511916 @default.
• W2991288125 cites W2127410754 @default.
• W2991288125 cites W2129144690 @default.
• W2991288125 cites W2134726513 @default.
• W2991288125 cites W2156694810 @default.
• W2991288125 cites W2218303215 @default.
• W2991288125 cites W2319893966 @default.
• W2991288125 cites W2336517685 @default.
• W2991288125 cites W2440755571 @default.
• W2991288125 cites W2509149598 @default.
• W2991288125 cites W2554773181 @default.
• W2991288125 cites W2570510763 @default.
• W2991288125 cites W2591304102 @default.
• W2991288125 cites W2606577423 @default.
• W2991288125 cites W2612650744 @default.
• W2991288125 cites W2732191012 @default.
• W2991288125 cites W2754938970 @default.
• W2991288125 cites W2759857871 @default.
• W2991288125 cites W2764045342 @default.
• W2991288125 cites W2776106451 @default.
• W2991288125 cites W2776547429 @default.
• W2991288125 cites W2783105903 @default.
• W2991288125 cites W2797957695 @default.
• W2991288125 cites W2803106137 @default.
• W2991288125 cites W2804179781 @default.
• W2991288125 cites W2811402315 @default.
• W2991288125 cites W2888322640 @default.
• W2991288125 cites W2888693280 @default.
• W2991288125 cites W2889882288 @default.
• W2991288125 cites W2891520965 @default.
• W2991288125 cites W2892792579 @default.
• W2991288125 cites W2895356076 @default.
• W2991288125 cites W2909584502 @default.
• W2991288125 cites W2911000961 @default.
• W2991288125 cites W2915631299 @default.
• W2991288125 cites W2921868990 @default.
• W2991288125 cites W2948847418 @default.
• W2991288125 cites W2955923353 @default.
• W2991288125 cites W4244618912 @default.
• W2991288125 doi "https://doi.org/10.1021/acsami.9b17223" @default.
• W2991288125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31763810" @default.
• W2991288125 hasPublicationYear "2019" @default.
• W2991288125 type Work @default.
• W2991288125 sameAs 2991288125 @default.
• W2991288125 citedByCount "23" @default.
• W2991288125 countsByYear W29912881252020 @default.
• W2991288125 countsByYear W29912881252021 @default.
• W2991288125 countsByYear W29912881252022 @default.
• W2991288125 countsByYear W29912881252023 @default.
• W2991288125 crossrefType "journal-article" @default.
• W2991288125 hasAuthorship W2991288125A5001549076 @default.
• W2991288125 hasAuthorship W2991288125A5015764177 @default.
• W2991288125 hasAuthorship W2991288125A5039037778 @default.
• W2991288125 hasAuthorship W2991288125A5071660837 @default.
• W2991288125 hasAuthorship W2991288125A5072931528 @default.
• W2991288125 hasAuthorship W2991288125A5083339231 @default.
• W2991288125 hasConcept C121608353 @default.
• W2991288125 hasConcept C126322002 @default.
• W2991288125 hasConcept C134306372 @default.
• W2991288125 hasConcept C150903083 @default.
• W2991288125 hasConcept C185592680 @default.
• W2991288125 hasConcept C192562407 @default.
• W2991288125 hasConcept C197336794 @default.
• W2991288125 hasConcept C202751555 @default.
• W2991288125 hasConcept C207001950 @default.
• W2991288125 hasConcept C2776694085 @default.
• W2991288125 hasConcept C2777529286 @default.
• W2991288125 hasConcept C2780306303 @default.
• W2991288125 hasConcept C2780427987 @default.

• next